January 9, 2009 - The 2009 Spring Radiology & Imaging Conference will be held May 6-8, 2009 at the Hyatt Regency in Miami, FL.

To receive “early bird pricing,” participants must register by Friday, Jan. 30 at www.hlthcp.com.

January 9, 2009 - Virtual Radiologic Corp. earned the top ranking for KLAS Teleradiology Services category in its 2008 "Top 20 Best in KLAS Awards" report.

January 8, 2009 - Two RSNA exhibits featuring Aquarius iNtuition by TeraRecon won Cum Laude awards at the recent 94th annual Radiological Society of North America (RSNA) Scientific Assembly at McCormick Place in Chicago, IL, Nov. 30 - Dec. 5, 2008.

January 9, 2009 – The Healthcare Information and Management Systems Society (HIMSS) is supporting former Senate Majority Leader Tom Daschle’s confirmation as Secretary of the U.S. Department of Health and Human Services (HHS).

January 8, 2009 - A newly identified gene, called metadherin, might cause breast cancer tumors to spread and become resistant to chemotherapy, according to a study published in the journal Cancer Cell.

January 8, 2009 – McKesson’s Paragon healthcare information solution was among seven McKesson solutions to be rated No. 1 in their categories in the 2008 Top 20 Best in KLAS Awards reports.

January 8, 2009 – Bayer Schering Pharma AG and Hamamatsu Photonics K.K., Japan have signed a licensing agreement for the use of novel substances in the field of molecular imaging for cancer, allowing the company to expand its existing molecular imaging portfolio in the area of cancer.

January 8, 2009 - The risk of developing cancer among radiation workers increases with the dose of ionizing radiation they are exposed to, according to a study by the Health Protection Agency published today in the British Journal of Cancer.

The cancer risks observed in the study are consistent with the international scientific consensus on radiation protection.

January 8, 2009 - Digital mammograms take longer to interpret than film-screen mammograms reported researchers in a study done at The University of Texas M.D. Anderson Cancer Center in Houston, TX.

January 8, 2009 – In a study published in the December issue of Journal of Clinical Oncology, results showed that [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) offered no additional value over computed tomography (CT) or tumor marker analysis (TMA) in predicting the histology of residual masses.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now